Astellas Pharma Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALPMY Over the counter 2830 www.astellas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Astellas Pharma Inc.

Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer - Oct 8th, 2026 6:30 am
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026 - Oct 6th, 2026 5:30 pm
New Preliminary Real-World VEOZAH™ (fezolinetant) Data Highlights Improvements in Menopause-Related Symptoms and Sleep Outcomes - Oct 2nd, 2026 6:00 am
Astellas Pharma Inc's Dividend Analysis - Sep 29th, 2026 5:11 am
ARTHEx Biotech Announces Appointment of Glenn P. Sblendorio as Chairman of the Board - Sep 29th, 2026 1:00 am
Astellas Pharma (TSE:4503) Stock Could Be 39% Below Fair Value On Cash Flow - Sep 26th, 2026 12:09 pm
Astellas lists 431K sf Northbrook HQ in possible sale-leaseback play - Sep 24th, 2026 9:24 am
Astellas Doses First Patient in Phase 3 Study of setidegrasib in Previously Treated KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer - Sep 23rd, 2026 5:30 pm
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President - Sep 2nd, 2026 4:00 pm
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers - Sep 1st, 2026 10:35 am
Mid-cap biotechs join Trump’s latest round of drug pricing deals - Sep 1st, 2026 6:14 am
Trump lines up MFN deals with nine mid-size pharmas on drug pricing push - Sep 1st, 2026 6:05 am
Trump's Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing - Aug 31st, 2026 7:59 pm
Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines - Aug 31st, 2026 4:00 pm
Trump Announces Drug Pricing Deals with Teva, 8 Other Companies - Aug 31st, 2026 3:52 pm
Astellas Pharma (TSE:4503) Doses First Patient In Phase 3 Gastric Cancer Trial - Aug 26th, 2026 8:12 am
Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma - Aug 24th, 2026 5:30 pm
New Strong Sell Stocks for August 19th - Aug 19th, 2026 3:56 am